
Bal Pharma Limited has informed the Exchange regarding a press release dated November 15, 2021, titled "BAL PHARMA Ltd reports H1FY22 financial results with 290% growth in PAT, lead by strong performance of its API business.".
Filed with NSE ·

Bal Pharma Limited has informed the Exchange regarding a press release dated November 15, 2021, titled "BAL PHARMA Ltd reports H1FY22 financial results with 290% growth in PAT, lead by strong performance of its API business.".
6ix hasn’t read this filing yet.
Follow Bal Pharma into a list and get an email when it puts out news.
Follow Bal Pharma